Can newly introduced 13-valent pneumococcal conjugate vaccine (PCV13) prevent acute otitis media among infants and children?

被引：0
|
作者：
Vicedomini, D. [1 ]
Vitale, A. [2 ]
Vega, G. R. [2 ]
Greco, N. [2 ]
机构：
[1] ASL Napoli Ctr, Naples, Italy
[2] San Giuseppe Moscati Hosp, Dept Pediat, Avellino, Italy
来源：
MINERVA PEDIATRICA | 2014年 / 66卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [41] Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV
    Ben-Shimol, Shalom
    Givon-Lavi, Noga
    Leibovitz, Eugene
    Raiz, Simon
    Greenberg, David
    Dagan, Ron
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1724 - 1732
  • [42] Policy Statement-Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
    Bocchini, Joseph A., Jr.
    Bradley, John S.
    Brady, Michael T.
    Bernstein, Henry H.
    Byington, Carrie L.
    Fisher, Margaret C.
    Glode, Mary P.
    Jackson, Mary Anne
    Keyserling, Harry L.
    Kimberlin, David W.
    Orenstein, Walter A.
    Schutze, Gordon E.
    Willoughby, Rodney E., Jr.
    PEDIATRICS, 2010, 126 (01) : 186 - 190
  • [43] THE COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) IN TAIWAN
    Wu, D. B. C.
    Chang, C. J.
    Chien, L.
    Fang, H. C. H.
    Roberts, C. S.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A602
  • [44] Improving Pneumococcal 13-valent Conjugate (PCV13) Vaccination Rates and Physician Documentation in the Geriatrics Clinic
    Sheikh, A.
    Phillips, S. C.
    Scott-Iriarte, S.
    Pravodelov, V.
    Lee, W.
    Jang, A.
    Pearse, M.
    Reaves, J.
    Tran, N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S167 - S167
  • [45] Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
    Mezquita, Miguel Angel Hernandez
    Boscam, Alexis Morales
    Sierra, Vanesa Hidalgo
    Ballesteros, Mercedes Sobrino
    Ferrero, Miguel Barrueco
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [46] Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
    Shen, Ching-Fen
    Chen, Ju-Ling
    Su, Chien-Chou
    Lin, Wen-Liang
    Hsieh, Min-Ling
    Liu, Ching-Chun
    Cheng, Ching-Lan
    VACCINES, 2021, 9 (09)
  • [47] A COMPARISON OF THE COST-EFFECTIVENESS OF THE 13-VALENT (PCV13) AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    VALUE IN HEALTH, 2009, 12 (07) : A428 - A428
  • [48] A Response to: Letter to the Editor Regarding "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants"
    Perdrizet, Johnna
    Horn, Emily K.
    Nua, Winniefer
    Perez-Peralta, Judith
    Nailes, Jennifer
    Santos, Jaime
    Ong-Lim, Anna
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) : 1301 - 1303
  • [49] A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
    Johnna Perdrizet
    Emily K. Horn
    Winniefer Nua
    Judith Perez-Peralta
    Jennifer Nailes
    Jaime Santos
    Anna Ong-Lim
    Infectious Diseases and Therapy, 2022, 11 : 1301 - 1303
  • [50] PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN AN INFLUENZA PANDEMIC IN SINGAPORE AND HONG KONG
    Rubin, J.
    McGarry, L.
    Klugman, K.
    Strutton, D.
    Gilmore, K.
    Hwang, S.
    Rinaldi, F.
    Weinstein, M.
    VALUE IN HEALTH, 2010, 13 (03) : A9 - A9
12345